التفاصيل البيبلوغرافية
| العنوان: |
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆ |
| المؤلفون: |
Wu, X.H., Zhu, J.Q., Yin, R.T., Yang, J.X., Liu, J.H., Wang, J., Wu, L.Y., Liu, Z.L., Gao, Y.N., Wang, D.B., Lou, G., Yang, H.Y., Zhou, Q., Kong, B.H., Huang, Y., Chen, L.P., Li, G.L., An, R.F., Wang, K., Zhang, Y., Yan, X.J., Lu, X., Lu, W.G., Hao, M., Wang, L., Cui, H., Chen, Q.H., Abulizi, G., Huang, X.H., Tian, X.F., Wen, H., Zhang, C., Hou, J.M., Mirza, M.R. |
| المصدر: |
In Annals of Oncology April 2021 32(4):512-521 |
| قاعدة البيانات: |
ScienceDirect |
